Aurinia Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.2% | +3.3% | +961.3% | -91.2% | +6.9% | -3.2% | -3.3% | +1,193.1% | -92.3% | +3.4% | -3.3% | +693.1% | -87.4% | +3.4% | -3.3% | +0.0% | +172,417.2% | -98.2% | +624.3% | +121.6% | +59.6% | -7.6% | +30.4% | +97.9% | -49.0% | +21.0% | +20.6% | +31.4% | -17.3% | +11.5% | +13.7% | +18.5% | -11.7% | +4.3% | +12.1% | +4.9% | +5.0% | +0.8% | +7.1% | – | |
| – | +0.0% | +0.0% | +710,600.0% | +52.1% | -19.6% | +2.3% | +18.2% | +6.2% | -2.8% | -1.9% | +4.9% | +59.5% | -25.3% | +4.1% | -19.9% | -56.7% | +329.5% | -99.8% | +541.7% | -17.5% | +89.4% | -46.8% | +524.6% | +53.0% | -44.3% | -69.1% | +271.3% | +333.1% | -20.3% | +43.7% | +14.9% | -32.3% | -8.0% | +54.4% | -17.0% | +19.5% | -0.4% | -23.2% | +0.8% | – | |
| – | -3.3% | +3.4% | -22,693.3% | – | – | – | – | – | – | – | – | – | – | – | -3.3% | +0.0% | +172,417.2% | -98.3% | +628.9% | +128.3% | +59.0% | -6.8% | +24.4% | +100.6% | -49.2% | +25.5% | +17.5% | +19.6% | -16.9% | +7.2% | +13.5% | +27.9% | -12.0% | -0.8% | +16.7% | +3.3% | +5.7% | +3.7% | +7.7% | – | |
| – | +63.4% | +34.1% | -3.0% | +52.1% | -19.6% | +2.3% | +18.2% | +6.2% | -2.8% | -1.9% | +4.9% | +59.5% | -25.3% | +4.1% | -19.9% | +10.5% | +7.6% | -25.4% | +2.6% | +98.9% | -44.4% | +13.2% | -8.7% | -4.8% | -10.1% | +33.3% | -3.9% | +7.5% | -24.8% | -45.7% | -26.5% | -25.3% | +166.1% | -29.2% | +29.4% | +13.5% | +29.2% | -31.4% | +74.7% | – | |
| – | +29.8% | +53.9% | -15.3% | -8.7% | +17.7% | +21.6% | -8.7% | -15.6% | +19.7% | +11.5% | +26.8% | +22.5% | +19.6% | +52.6% | +39.7% | +98.7% | +30.5% | -0.6% | +11.3% | +0.7% | -0.9% | +2.2% | +14.0% | +1.2% | -9.0% | +5.6% | -12.9% | +9.4% | +4.8% | -11.3% | -8.4% | -7.0% | -17.7% | -37.8% | +29.9% | +1.6% | +11.3% | -23.8% | +8.3% | – | |
| – | +48.6% | +38.0% | -6.6% | +33.2% | -11.9% | +7.5% | +9.9% | +0.8% | +1.4% | +1.5% | +10.5% | +47.1% | -154.7% | – | -0.7% | +57.5% | +37.2% | -11.5% | +4.0% | +21.2% | -14.1% | +6.5% | +5.6% | +0.4% | -12.2% | +15.2% | -11.8% | +14.1% | -5.8% | -11.7% | -6.5% | +0.4% | +12.0% | -42.8% | +33.6% | -17.7% | +0.5% | -15.9% | +1.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -114.2% | – | -8.1% | +48.1% | +11.7% | +24.6% | +11.9% | – | |
| – | +0.0% | +985.7% | +451.3% | -4.8% | -52.1% | +25.7% | +163.3% | +9.3% | -2.9% | -98.4% | -9.1% | -10.0% | +0.0% | +177.8% | +212.0% | +29.5% | +235.6% | -49.3% | -17.4% | -25.4% | +2.8% | +140.4% | +84.4% | +203.1% | +98.7% | +31.1% | -98.3% | +2,053.8% | -6.4% | -2.1% | -6.6% | +0.8% | -5.1% | -6.9% | +4.7% | -1.6% | +492.7% | -84.5% | -6.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +901.8% | -92.1% | +1,975.8% | -9.0% | +44.3% | +11.7% | +23.1% | +11.1% | – | |
| – | -84.8% | +13,164.9% | -118.7% | – | – | – | -43.8% | +209.7% | -98.3% | -82.2% | +23.1% | +56.3% | +260.0% | -364.4% | – | -850.0% | – | -94.9% | +125.0% | -55.6% | +8,975.0% | -98.6% | -10.0% | +10,500.0% | -10.4% | -49.0% | -247.2% | – | +54.0% | +61.0% | +2.3% | -39.6% | -156.0% | – | -36.0% | -36.1% | -42,704.4% | – | +18.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,887.5% | -90.0% | +1,533.6% | -7.8% | +46.7% | +568.1% | -83.7% | +8.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +178.1% | -65.7% | +321.6% | -7.1% | +30.9% | +27.8% | +5.7% | +9.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.